Human neutrophil peptides 1-3 as gastric cancer tissue markers measured by MALDI-imaging mass spectrometry: Implications for infiltrated neutrophils as a tumor target

Disease Markers

Volumn 32, Issue 1, 2012, Pages 21-31

  Cheng, Chun Chia ^a,b   Chang, Jungshan ^a,d,e   Chen, Ling Yun ^f   Ho, Ai Sheng ^g   Huang, Ker Jer ^h   Lee, Shui Cheng ^b   Mai, Fu Der ^a,c,d   Chang, Chun Chao ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^g CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^h Chung Shan Institute of Technology Lungtan   (Taiwan)

Author keywords

biomarker; Gastric cancer; human neutrophil peptides 1 3; MALDI TOF MS

Indexed keywords

DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; PEPTIDE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LAMINA PROPRIA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 84863063515     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-0857     Document Type: Article

References (34)

1. L. Yang, Incidence and mortality of gastric cancer in China, World J Gastroenterol 12 (2006), 17-20. (Pubitemid 43126077)
2. C.J. Chen, S.L. You, L.H. Lin, W.L. Hsu and Y.W. Yang, Cancer epidemiology and control in Taiwan: a brief review, Jpn J Clin Oncol 32 Suppl (2002), S66-S81.
3. M. McCracken, M. Olsen, M.S. Chen, Jr., A. Jemal, M. Thun, V. Cokkinides, D. Deapen and E. Ward, Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities, CA Cancer J Clin 57 (2007), 190-205. (Pubitemid 47312080)
4. D.M. Parkin, F. Bray, J. Ferlay and P. Pisani, Global cancer statistics, 2002, CA Cancer J Clin 55 (2005), 74-108. (Pubitemid 40372904)
5. A. Amin, H. Gilmour, L. Graham, S. Paterson-Brown, J. Terrace and T.J. Crofts, Gastric adenocarcinoma missed at en-doscopy, J R Coll Surg Edinb 47 (2002), 681-684.
6. J. Albrethsen, R. Bogebo, S. Gammeltoft, J. Olsen, B. Winther and H. Raskov, Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study, BMC Cancer 5 (2005), 8.
7. J. Albrethsen, C.H. Moller, J. Olsen, H. Raskov and S. Gam-meltoft, Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer, Eur J Cancer 42 (2006), 3057-3064. (Pubitemid 44679822)
8. D.A. Holterman, J.I. Diaz, P.F. Blackmore, J.W. Davis, P.F. Schellhammer, A. Corica, O.J. Semmes and A. Vlahou, Over-expression of alpha-defensin is associated with bladder cancer invasiveness, Urol Oncol 24 (2006), 97-108. (Pubitemid 43340166)
9. C.A. Muller, J. Markovic-Lipkovski, T. Klatt, J. Gamper, G. Schwarz, H. Beck, M. Deeg, H. Kalbacher, S. Widmann, J.T. Wessels et al., Human alpha-defensins HNPs-1,-2, and-3 in renal cell carcinoma: influences on tumor cell proliferation, Am J Pathol 160 (2002), 1311-1324. (Pubitemid 34411635)
10. F.T. Lundy, D.F. Orr, J.R. Gallagher, P. Maxwell, C. Shaw, S.S. Napier, C. Gerald Cowan, P.J. Lamey and J.J. Marley, Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue, Oral Oncol 40 (2004), 139-144. (Pubitemid 38030356)
11. J.A. Bauer, A.B. Chakravarthy, J.M. Rosenbluth, D. Mi, E.H. Seeley, N. De Matos Granja-Ingram, M.G. Olivares, M.C. Kelley, I.A. Mayer, I.M. Meszoely et al., Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation, Clin Cancer Res 16 (2010), 681-690.
12. N. Droin, J.B. Hendra, P. Ducoroy and E. Solary, Human defensins as cancer biomarkers and antitumour molecules, J Proteomics 72 (2009), 918-927.
13. O.L. Kon, T.T. Yip, M.F. Ho, W.H. Chan, W.K. Wong, S.Y. Tan, W.H. Ng, S.Y. Kam, A. Eng, P. Ho, et al, The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile, BMC Med Genomics 1 (2008), 54.
14. Y. Mohri, T. Mohri, W. Wei, Y.J. Qi, A. Martin, C. Miki, M. Kusunoki, D.G. Ward and P.J. Johnson, Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer, Br J Cancer 101 (2009), 295-302.
15. H.K. Kim, M.L. Reyzer, I.J. Choi, C.G. Kim, H.S. Kim, A. Oshima, O. Chertov, S. Colantonio, R.J. Fisher, J.L. Allen, et al, Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry, J Proteome Res 9 (2010), 4123-4130.
16. P. Chaurand, J.L. Norris, D.S. Cornett, J.A. Mobley, R.M. Caprioli, New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry, J Proteome Res 5 (2006), 2889-2900. (Pubitemid 44749207)
17. H. Meistermann, J.L. Norris, H.R. Aerni, D.S. Cornett, A. Friedlein, A.R. Erskine, A. Augustin, M.C. De Vera Mudry, S. Ruepp, L. Suter, et al, Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat, Mol Cell Proteomics 5 (2006), 1876-1886. (Pubitemid 44688196)
18. P. Chaurand, S. Fouchecourt, B.B. DaGue, B.J. Xu, M.L. Reyzer, M.C. Orgebin-Crist and R.M. Caprioli, Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry, Proteomics 3 (2003), 2221-2239. (Pubitemid 37414087)
19. B.K. Kaletas, I.M. van der Wiel, J. Stauber, C. Guzel, J.M. Kros, T.M. Luider, R.M. Heeren, Sample preparation issues for tissue imaging by imaging MS, Proteomics 9(2009), 2622-2633.
20. F.T. Lundy, D.F. Orr, C. Shaw, P.J. Lamey and G.J. Linden, Detection of individual human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in unfractionated gingi-val crevicular fluid-a MALDI-MS approach, Mol Immunol 42 (2005), 575-579. (Pubitemid 39655935)
21. H. Isomoto, H. Mukae, H. Ishimoto, Y. Date, Y. Nishi, K. Inoue, A. Wada, T. Hirayama, M. Nakazato, S. Kohno, Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection, Am J Gastroenterol 99 (2004), 1916-1923. (Pubitemid 39421233)
22. A. Mantovani, P. Allavena, A. Sica and F. Balkwill, Cancer-related inflammation, Nature 454 (2008), 436-444.
23. Z.G. Fridlender, J. Sun, S. Kim, V. Kapoor, G. Cheng, L. Ling, G.S. Worthen and S.M. Albelda, Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN, Cancer Cell 16 (2009), 183-194.
24. P.M. Hofman, Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis, World J Gas-troenterol 16 (2010), 5790-5800.
25. H. Shimada, N. Takiguchi, O. Kainuma, H. Soda, A. Ikeda, A. Cho, A. Miyazaki, H. Gunji, H. Yamamoto and M. Nagata, High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer, Gastric Cancer 13 (2010), 170-176.
26. H. Cho, H.W. Hur, S.W. Kim, S.H. Kim, J.H. Kim, Y.T. Kim, K. Lee, Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment, Cancer Immunol Immunother 58 (2009), 15-23.
27. H. Cho and J.H. Kim, Multiplication of neutrophil and mono-cyte counts (MNM) as an easily obtainable tumour marker for cervical cancer, Biomarkers 14 (2009), 161-170.
28. S. Tazzyman, S.T. Barry, S. Ashton, P. Wood, D. Blakey, C.E. Lewis and C. Murdoch, Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth, Int J Cancer (2011).
29. L.W. Locke, M.D. Chordia, Y. Zhang, B. Kundu, D. Kennedy, J. Landseadel, L. Xiao, K.D. Fairchild, S.S. Berr, J. Linden and D. Pan, A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu, J Nucl Med 50 (2009), 790-797.
30. J.S. Mader and D.W. Hoskin, Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment, Expert Opin Investig Drugs 15 (2006), 933-946. (Pubitemid 44177845)
31. S.T. McKeown, F.T. Lundy, J. Nelson, D. Lockhart, C.R. Ir-win, C.G. Cowan and J.J. Marley, The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squa-mous cell carcinoma (OSCC) in vitro, Oral Oncol 42 (2006), 685-690. (Pubitemid 44094234)
32. S. Ghavami, A. Asoodeh, T. Klonisch, A.J. Halayko, K. Kad-khoda, T.J. Kroczak, S.B. Gibson, E.P. Booy, H. Naderi-Manesh and M. Los, Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway, J Cell Mol Med 12 (2008), 1005-1022. (Pubitemid 351718078)
33. N. Xu, Y.S. Wang, W.B. Pan, B. Xiao, Y.J. Wen, X.C. Chen, L.J. Chen, H.X. Deng, J. You, B. Kan, et al, Human alpha-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice, Mol Cancer Ther 7 (2008), 1588-1597.
34. J. Aarbiou, G.S. Tjabringa, R.M. Verhoosel, D.K. Ninaber, S.R. White, L.T. Peltenburg, K.F. Rabe and P.S. Hiemstra, Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37, Inflamm Res 55 (2006), 119-127.